• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恰加斯病不确定型患者外周淋巴细胞中P2X7受体表达及免疫谱评估

Evaluation of P2X7 receptor expression in peripheral lymphocytes and immune profile from patients with indeterminate form of Chagas disease.

作者信息

Souza Viviane do Carmo Gonçalves, Dos Santos Joabel Tonellotto, Cabral Fernanda Licker, Barbisan Fernanda, Azevedo Maria Isabel, Dias Carli Luiz Felipe, de Avila Botton Sonia, Dos Santos Jaques Jeandre Augusto, Rosa Leal Daniela Bitencourt

机构信息

Department of Microbiology and Parasitology, Health Sciences Center, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil.

Department of Large Animal Clinic de Clínica, Rural Sciences Center, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil.

出版信息

Microb Pathog. 2017 Mar;104:32-38. doi: 10.1016/j.micpath.2017.01.002. Epub 2017 Jan 3.

DOI:10.1016/j.micpath.2017.01.002
PMID:28062289
Abstract

Chagas disease (CD) is caused by Trypanosoma cruzi, an intracellular protozoan which is a potent stimulator of cell-mediated immunity. In the indeterminate form of CD (IFCD) a modulation between pro- and anti-inflammatory responses establishes a host-parasite adaptation. It was previously demonstrated that purinergic ecto-enzymes regulates extracellular ATP and adenosine levels, influencing immune and inflammatory processes during IFCD. In inflammatory sites ATP, as well as its degradation product, adenosine, function as signaling molecules and immunoregulators through the activation of purinergic receptors. In this work, it was analyzed the gene and protein expression of P2X7 purinergic receptor in peripheral lymphocytes and serum immunoregulatory cytokines from IFCD patients. Gene and protein expression of P2X7 receptor (P2X7R), and serum cytokines (IL-2, IL-10, IL-17 and IFN-γ) were unaltered. However, IFCD group showed significantly higher IL-4 and IL-6 levels while TNF-α was significantly decreased. These results indicate that imune profile of IFCD patients displays anti-inflammatory characteristics, consistent with the establishment of an immunomodulatory response. Further study about the molecular knowledge of P2X7R in IFCD is useful to clarify the participation of purinergic system in the regulatory mechanism which avoid the progression of CD.

摘要

恰加斯病(CD)由克氏锥虫引起,克氏锥虫是一种细胞内原生动物,是细胞介导免疫的强效刺激物。在CD的无症状感染期(IFCD),促炎反应和抗炎反应之间的调节建立了宿主与寄生虫的适应性。先前已证明,嘌呤能外切酶调节细胞外ATP和腺苷水平,影响IFCD期间的免疫和炎症过程。在炎症部位,ATP及其降解产物腺苷通过激活嘌呤能受体发挥信号分子和免疫调节剂的作用。在这项研究中,分析了IFCD患者外周淋巴细胞中P2X7嘌呤能受体的基因和蛋白表达以及血清免疫调节细胞因子。P2X7受体(P2X7R)的基因和蛋白表达以及血清细胞因子(IL-2、IL-10、IL-17和IFN-γ)未发生改变。然而,IFCD组的IL-4和IL-6水平显著升高,而TNF-α显著降低。这些结果表明,IFCD患者的免疫特征表现出抗炎特性,这与免疫调节反应的建立一致。进一步研究IFCD中P2X7R的分子知识,有助于阐明嘌呤能系统在避免CD进展的调节机制中的作用。

相似文献

1
Evaluation of P2X7 receptor expression in peripheral lymphocytes and immune profile from patients with indeterminate form of Chagas disease.恰加斯病不确定型患者外周淋巴细胞中P2X7受体表达及免疫谱评估
Microb Pathog. 2017 Mar;104:32-38. doi: 10.1016/j.micpath.2017.01.002. Epub 2017 Jan 3.
2
E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.不确定型恰加斯病患者淋巴细胞中的E-NTPD酶和E-ADA活性发生改变。
Parasitol Int. 2012 Dec;61(4):690-6. doi: 10.1016/j.parint.2012.07.008. Epub 2012 Jul 27.
3
Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.来自单核细胞的炎症介质可下调细胞增殖,并增强恰加斯病两种极端临床类型患者的细胞因子生成。
Hum Immunol. 2014 Jan;75(1):20-8. doi: 10.1016/j.humimm.2013.09.009. Epub 2013 Sep 24.
4
Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease.嘌呤能系统的细胞外酶参与了不定型恰加斯病患者的血栓调节。
Purinergic Signal. 2012 Dec;8(4):753-62. doi: 10.1007/s11302-012-9322-7. Epub 2012 Jul 1.
5
Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.嘌呤能受体和 NOD 样受体家族蛋白 3-炎症小体通路在三磷酸腺苷诱导巨噬细胞细胞因子释放中的作用。
Clin Exp Pharmacol Physiol. 2014 Apr;41(4):279-86. doi: 10.1111/1440-1681.12214.
6
Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.克氏锥虫感染会导致来自无症状型和心脏型恰加斯病患者的单核细胞和T细胞对共刺激分子和细胞因子产生不同的调节作用。
Infect Immun. 2007 Apr;75(4):1886-94. doi: 10.1128/IAI.01931-06. Epub 2007 Feb 5.
7
Chagas disease, COVID-19 and P2X7 receptor.恰加斯病、新冠病毒病与P2X7受体
Scand J Immunol. 2022 Mar;95(3):e13135. doi: 10.1111/sji.13135. Epub 2022 Jan 6.
8
Human beta-defensin-2 and -3 enhance pro-inflammatory cytokine expression induced by TLR ligands via ATP-release in a P2X7R dependent manner.人β-防御素-2和-3通过P2X7R依赖性的ATP释放增强TLR配体诱导的促炎细胞因子表达。
Immunobiology. 2016 Nov;221(11):1259-65. doi: 10.1016/j.imbio.2016.06.006. Epub 2016 Jun 19.
9
Peripheral P2X7 receptor-induced mechanical hyperalgesia is mediated by bradykinin.外周P2X7受体诱导的机械性痛觉过敏由缓激肽介导。
Neuroscience. 2014 Sep 26;277:163-73. doi: 10.1016/j.neuroscience.2014.06.057. Epub 2014 Jul 2.
10
Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.在查加斯病早期不确定阶段进行苯硝唑治疗,可使先天性和适应性免疫细胞的细胞因子表达向1型调节的免疫谱转变。
Scand J Immunol. 2006 Nov;64(5):554-63. doi: 10.1111/j.1365-3083.2006.01843.x.

引用本文的文献

1
The inhibitory effect of Yam polysaccharides on acrylamide-induced programmed cell death in RAW 264.7 cells.山药多糖对丙烯酰胺诱导的RAW 264.7细胞程序性细胞死亡的抑制作用。
Food Sci Nutr. 2022 Sep 27;11(1):443-457. doi: 10.1002/fsn3.3076. eCollection 2023 Jan.
2
Purinergic modulation of the immune response to infections.嘌呤能调制感染免疫应答。
Purinergic Signal. 2022 Mar;18(1):93-113. doi: 10.1007/s11302-021-09838-y. Epub 2022 Jan 8.
3
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue.
针对嘌呤能受体抑制 SARS-CoV-2 感染肺组织中细胞因子风暴。
Int Immunopharmacol. 2021 Nov;100:108150. doi: 10.1016/j.intimp.2021.108150. Epub 2021 Sep 13.
4
P2RX7 at the Host-Pathogen Interface of Infectious Diseases.P2RX7 在感染性疾病的宿主-病原体界面上的作用。
Microbiol Mol Biol Rev. 2021 Jan 13;85(1). doi: 10.1128/MMBR.00055-20. Print 2021 Feb 17.
5
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?炎症性疾病中的P2X7受体:天使还是恶魔?
Front Pharmacol. 2018 Feb 6;9:52. doi: 10.3389/fphar.2018.00052. eCollection 2018.
6
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.P2X7 受体作为治疗靶点的潜力,包括炎症和肿瘤进展。
Purinergic Signal. 2018 Mar;14(1):1-18. doi: 10.1007/s11302-017-9593-0. Epub 2017 Nov 21.